Benefits
Post-exercise muscle recovery and reduced soreness
Multiple clinical trials show tart cherry supplementation reduces muscle soreness, strength loss, and recovery time after intense exercise. Effect sizes are modest but consistent across trials. Most useful for athletes doing multiple training sessions in close succession or competing in endurance events.
Sleep quality improvement
Tart cherry contains naturally-occurring melatonin (relatively high among food sources). Clinical trials show tart cherry juice or extract before bedtime improves sleep duration, efficiency, and quality. Effects are modest compared to pharmaceutical melatonin but useful as a food-based sleep aid.
Uric acid reduction and gout support
Clinical evidence shows tart cherry consumption reduces serum uric acid levels and may decrease gout flare frequency. Effect mechanism involves anthocyanin-mediated inhibition of xanthine oxidase (the same target as allopurinol, but milder). Useful adjunct to standard gout management.
Anti-inflammatory effects
Tart cherry anthocyanins inhibit COX-1, COX-2, and prostaglandin pathways — providing NSAID-like anti-inflammatory effects without the GI and cardiovascular concerns of long-term NSAID use. Mechanism explains the exercise recovery and uric acid benefits.
Cardiovascular biomarker support
Emerging evidence suggests tart cherry may modestly support cardiovascular biomarkers including blood pressure, lipids, and inflammation markers. Less robust than the exercise recovery and sleep evidence; promising but not yet definitively established.
Antioxidant capacity
Tart cherry has high antioxidant capacity (among the highest of common fruits) due to its anthocyanin content. Generic dietary antioxidant benefits with food-grade safety profile suitable for long-term use.
Form selection guidance
Juice provides whole-food matrix and melatonin but with sugar content; concentrate is sugar-free but lacks fiber; capsule extract provides standardized dosing without taste issues. Sweetened tart cherry products dilute the active compound concentration.
Mechanism of action
COX-1/COX-2 inhibition and prostaglandin reduction
Anthocyanins from tart cherry inhibit cyclooxygenase enzymes that produce prostaglandins — the primary mediators of exercise-induced inflammation and pain. This NSAID-like mechanism reduces post-exercise soreness without the GI side effects of pharmaceutical COX inhibitors.
Melatonin-mediated sleep promotion
Tart cherries contain 13.5 ng/g melatonin — among the highest of any plant food. Combined with tryptophan (melatonin precursor) and serotonin present in tart cherry, supplementation produces physiologically meaningful increases in urinary melatonin metabolites and improved sleep architecture.
Xanthine oxidase inhibition and urate lowering
Tart cherry anthocyanins inhibit xanthine oxidase, the enzyme that catalyzes the final two steps of uric acid biosynthesis from hypoxanthine and xanthine. This mechanism directly reduces uric acid production, complementing the renal urate excretion effects of cherry consumption.
Clinical trials
Clinical trial of tart cherry juice (240 mL twice daily) vs. placebo in 20 marathon runners for 5 days before and 2 days after a marathon.
20 trained marathon runners. 7-day supplementation spanning race day.
Tart cherry group showed 20% less post-race strength loss, significantly lower inflammatory markers (IL-6, CRP), and faster recovery of isometric strength. Supports tart cherry as effective endurance recovery aid.
Clinical trial of tart cherry juice (240 mL twice daily) vs. placebo in 20 older adults with insomnia for 2 weeks.
20 older adults with insomnia. 2-week intervention.
Tart cherry juice significantly increased total sleep time (+39 min), sleep efficiency (+6%), and reduced insomnia severity vs. placebo. Urinary melatonin metabolites significantly increased. Well-tolerated.
Prospective study examining tart cherry consumption and gout attack frequency in 633 gout patients over 2 years.
633 gout patients. 2-year prospective follow-up.
Tart cherry consumption was associated with 35% lower risk of gout attacks vs. no consumption. Daily consumption reduced risk by 45%. Effect significantly enhanced by concurrent allopurinol use.